Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -40,285 | -20,912 | N/A |
| Depreciation Amortization | 622 | 501 | N/A |
| Accounts payable and accrued liabilities | -512 | 541 | N/A |
| Other Working Capital | 1,752 | 1,013 | N/A |
| Other Operating Activity | 3,023 | -168 | 0 |
| Operating Cash Flow | $-35,400 | $-19,025 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -700 | -257 | N/A |
| Investing Cash Flow | $-700 | $-257 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 7,000 | 3,000 | N/A |
| Debt Repayment | -750 | N/A | N/A |
| Common Stock Issued | 268 | 53 | N/A |
| Other Financing Activity | 74,835 | 14,939 | 0 |
| Financing Cash Flow | $81,353 | $17,992 | $N/A |
| Beginning Cash Position | 1,987 | 3,277 | N/A |
| End Cash Position | 47,240 | 1,987 | N/A |
| Net Cash Flow | $45,253 | $-1,290 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -35,400 | -19,025 | N/A |
| Capital Expenditure | -700 | -257 | N/A |
| Free Cash Flow | -36,100 | -19,282 | 0 |